Despite rigorous disinfection and fumigation, healthcare-associated infection (HAI) remains a significant concern in healthcare settings. We have developed a novel airborne-microbicidal technology ‘ZeBox’ which clears >99.999% of airborne microbial load under controlled laboratory conditions.
To evaluate the clinical performance of ZeBox in reducing airborne and surface microbial load.
The study was conducted in single-bed and multi-bed intensive care units (ICUs) of two hospitals. Airborne and surface microbial loads were sampled pre and post deployment of ZeBox at pre-determined sites. Statistical significance of the reduction was determined using the Mann–Whitney U-test.
ZeBox brought statistically significant reduction of both airborne and surface bacterial and fungal load. In both hospital ICUs, airborne and surface bacterial load decreased by 90% and 75% on average respectively, providing a low bioburden zone of 10–15 feet diameter around the unit. The reduced microbial level was maintained during ZeBox's operation over several weeks. Most clinical bacterial isolates recovered from one of the hospitals were antibiotic resistant, highlighting ZeBox's ability to eliminate antimicrobial-resistant bacteria among others.
ZeBox significantly reduces airborne and surface microbial burden in clinical settings. It thereby serves an unmet need for reducing the incidence of HAI.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Hospital Infection
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis.Lancet. 2011; 377: 228-241
- The role of the hospital environment in the epidemiology of multi-resistant bacteria.J Hosp Infect. 1999; 43: 13-17
- Survival of bacterial and mold spores in air filter media.Atmos Environ. 2001; 35: 105-113
- Novel non-intrusive continuous use ZeBox technology to trap and destroy airborne microbes.Scient Rep. 2021; 11: 1-9
- Can commonly-used fan-driven air cleaning technologies improve indoor air quality? A literature review.Atmos Environ. 2011; 45: 4329-4343
- COVID-19 outbreak and hospital air quality: a systematic review of evidence on air filtration and recirculation.Environ Sci Technol. 2020; 55: 4134-4147
- A systematic review and meta-analysis of indoor bioaerosols in hospitals: the influence of heating, ventilation, and air conditioning.PLoS One. 2021; 16e0259996
- Continuous monitoring of aerial bioburden within intensive care isolation rooms and identification of high-risk activities.J Hosp Infect. 2019; 103: 185-192
- Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories.Clin Microbiol Infect. 2008; 14: 908-934
- Bacterial contamination in health care centers: differences between urban and rural settings.Atmosphere. 2021; 12: 450
- Dissemination of antimicrobial resistance in microbial ecosystems through horizontal gene transfer.Front Microbiol. 2016; 7: 173
- Resuspension of dust particles in a chamber and associated environmental factors.Aerosol Sci Technol. 2008; 42: 566-578
- Computational fluid dynamics study of human-induced wake and particle dispersion in indoor environment.Indoor Built Environ. 2017; 26: 185-198
- Seasonal variation of airborne viable bacterial pollution in Bengaluru urban, Karnataka, India.Environ Sci Ind J. 2017; 13: 145
- Performance evaluation of a new mobile air-treatment technology at-rest and under normal work conditions in a conventional hematology room.Health Technol. 2020; 10: 1591-1602
- Evaluation of a new mobile system for protecting immune-suppressed patients against airborne contamination.Am J Infect Control. 2007; 35: 460-466
- Reduced fungal contamination of the indoor environment with the PlasmairTM system (Airinspace).J Hosp Infect. 2007; 65: 156-162
- Effectiveness of a plasma treatment device on microbial air quality in a hospital ward, monitored by culture.J Hosp Infect. 2021; 108: 109-112
- Healthcare-associated infection impact with bioaerosol treatment and COVID-19 mitigation measures.J Hosp Infect. 2021; 116: 69-77
Published online: February 15, 2022
Accepted: February 3, 2022
Received: December 8, 2021
© 2022 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.